In clinical trials

Sexual & reproductive

Kisspeptin-10

Evidence

Early clinical research

Class

Fragment of kisspeptin

/

Kisspeptin-10

KEY TAKEAWAY

Kisspeptin-10 is a short fragment of the kisspeptin hormone that triggers release of GnRH. It is being studied in early trials for fertility treatment and is not approved.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

A fragment of the hormone that triggers reproductive signaling

Studied for

Fertility treatment and reproductive hormone disorders

Key fact

Stimulated reproductive hormone release in early human studies

Route

Injection (investigational)

Evidence strength

Early clinical research

What it is

What it is

Kisspeptin-10 is a ten-amino-acid active region of kisspeptin, a brain hormone that controls the reproductive axis.

How it works

How it works

It stimulates GnRH neurons, which signal the pituitary to release hormones that drive ovulation and testosterone production.

Regulatory status

Regulatory status

Kisspeptin-10 is not approved by the FDA. It is used only in research settings.

What it is used for

What it is used for

Investigated for infertility, including triggering egg maturation, and for hormone disorders.

Side effects and risks

Side effects and risks

Short-term injections were well tolerated in small studies. Long-term effects are unknown.

Citations

Citations

Primary literature for this entry is being compiled.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo